健世科技－Ｂ (9877.HK)

4.730 +0.540 (+12.89%) 收市：04:08PM HKT

健世科技－Ｂ

Block 5, B Area
No. 777 Binhai 4th Road Hangzhou Bay New Area
Ningbo
China
86 57 4639 35666
https://www.jenscare.com

版塊: Healthcare
行業: Medical Devices
全職員工: 376

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Shiwen Lv	Chairman, CEO & CTO	2.71M	無	1969
Mr. Fei Pan	CFO, VP & Executive Director	2.4M	無	1985
Mr. Yuanyuan Li	Joint Company Secretary	無	無	1986
Mr. Wai Chiu Wong FCS	Joint Company Secretary	無	無	1956
Mr. Biao Li	Vice President	490.62k	無	1985
Mr. Bo Hu	IT Director & Supervisor	無	無	1990

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.

公司管治

截至 無 止，健世科技－Ｂ 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。